ADE
Cytarabine (Ara-C), Daunorubicin, Etoposide · Induction Chemotherapy Regimen
Indications & Uses
Induction therapy for Acute Myeloid Leukemia (AML) in pediatric and adult patients.
Contraindications
Severe cardiac failure, severe refractory bone marrow aplasia unrelated to leukemia.
Side Effects & Warnings
Profound pancytopenia, bleeding, febrile neutropenia, mucositis, cardiotoxicity.
Drug & Dietary Interactions
Extensive interactions; consult specific multi-agent administration and hydration protocols.
For educational and informational purposes only. Do not alter medication doses or regimens without consulting your licensed oncology physician or care team.
Patient & Caregiver Support
Ask About This Medication
Connect with an ONC-ORG counselor regarding drug access, copay relief, patient assistance programs, or related clinical trials.